Physician profile
Praveen Raju Chenna
NPI 1295932689
$255,291.83
in general payments reported to CMS, 2019-2025
14 companies · $63K in 2025
The $63K reported for 2025 was more than what 98% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,939 · 2020: $76.35 · 2021: $1,216 · 2022: $2,022 · 2023: $39K · 2024: $149K · 2025: $63K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $152K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $49K · Travel and Lodging: $28K · Consulting Fee: $14K · Food and Beverage: $7,898.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $151,913.75 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $48,502.50 |
| Travel and Lodging | $27,553.42 |
| Consulting Fee | $14,170.00 |
| Food and Beverage | $7,897.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $142,563.57 | 2022-2025 | Da Vinci Surgical System, Ion, Da Vinci Sp |
| Emd Serono, INC. | $40,432.88 | 2023-2024 | Tepmetko, Bavencio |
| Olympus Corporation of The Americas | $36,191.91 | 2025 | Spiration Valve System |
| Olympus America INC. | $28,462.41 | 2019-2025 | Spiration Valve System, Single-Use Flexible Video Bronchoscope, Spin Vision Video Processor |
| Merit Medical Systems INC | $3,800.00 | 2024 | Aeromini Stent & Del Sys, Aero Stent and Delivery System |
| Pinnacle Biologics, INC | $1,171.75 | 2021 | |
| Shire North American Group INC | $1,050.00 | 2019 | |
| Boston Scientific Corporation | $558.20 | 2019-2021 | |
| Abbvie INC. | $475.00 | 2024 | |
| Ethicon INC. | $453.44 | 2019-2022 | |
| Melinta Therapeutics, LLC | $76.35 | 2020 | |
| Galvanize Therapeutics, INC | $21.43 | 2024 | Aliya System |
| Eagle Pharmaceuticals, INC. | $18.74 | 2023 | |
| Ascendis Pharma Endocrinology INC | $16.15 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Praveen Chenna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.